PMID: 9535604Apr 16, 1998Paper

Treatment for advanced testicular cancer with high-dose chemotherapy and autologous blood stem cell transplantation

International Journal of Urology : Official Journal of the Japanese Urological Association
A TakahashiT Tsukamoto

Abstract

This study was carried out to investigate the efficacy and safety of high-dose chemotherapy (HDC) for the treatment of patients with advanced testicular cancer. Seven patients were treated with high-dose carboplatin, etoposide, and ifosfamide followed by autologous blood stem cell transplantation. One patient received 1 cycle, 4 patients received 2 cycles, and 2 patients received 3 cycles of HDC. We performed a total of 15 autologous blood stem cell transplantations: 8 with autologous bone marrow; 6 with peripheral blood stem cells; and 1 with peripheral blood stem cells in addition to autologous bone marrow. Four of the 7 patients achieved a pathologic complete response via early use of HDC and additional salvage surgery. All 4 patients are still alive without evidence of disease at 12, 30, 33, and 54 months, respectively. One patient is alive with active disease at 35 months. Two patients refractory to conventional chemotherapy died of progressive disease at 5 and 27 months, respectively. The hematologic recovery after HDC was rapid, and peripheral blood stem cells tended to have shorter hematologic recovery compared with those from autologous bone marrow, although the difference was not significant. Nonhematologic toxicity w...Continue Reading

References

Apr 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C R NicholsD L Trump
Nov 18, 1992·Journal of the National Cancer Institute·R J Motzer, G J Bosl
Mar 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R BirchF A Greco
Jul 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C R NicholsS N Wolff
Jan 1, 1981·Cancer·A B MillerA Winkler
Jun 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BeyerW Stieger
Mar 24, 1994·The New England Journal of Medicine·J O Armitage
Oct 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K MargolinM Tetef
Oct 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BeyerW Siegert

❮ Previous
Next ❯

Citations

Jan 1, 1994·Clinical Oncology : a Journal of the Royal College of Radiologists·M P Williams, C A Roobottom

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
S J HarlandA Horwich
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
V Vongvises
International Journal of Urology : Official Journal of the Japanese Urological Association
Norio NonomuraAkihiko Okuyama
Annals of Oncology : Official Journal of the European Society for Medical Oncology
J ShamashT Oliver
© 2022 Meta ULC. All rights reserved